Search clinical trials for: AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold

Total 229 results

Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT II)

Myocardial Ischemia | Coronary Artery Disease

Colombia, Italy
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT)

Myocardial Ischemia | Coronary Artery Disease

Italy
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (RENASCENT III)

Myocardial Ischemia | Coronary Artery Disease

Italy, Colombia
Amaranth Medical Inc.

Unknown

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (MEND II)

Myocardial Ischemia | Coronary Artery Disease

Colombia
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Coronary Artery Disease

New Zealand, Belgium, Germany, Poland, Denmark, Brazil
Inova Health Care Services

Withdrawn

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

Coronary Artery Disease

United States
Umberto I Hospital, Frosinone Italy

Unknown

Study of ABSORB Stent in Acute Myocardial Infarction (ABSORB-ACS)

Acute Myocardial Infarction | Artery; Deformity, Coronary (Acquired)

Italy
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance (HOWTO-BRS)

Coronary Stenosis

Korea, Republic of
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Elixir Medical Corporation

Completed

Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry

Coronary Artery Disease

Belgium, Brazil
Papworth Hospital NHS Foundation Trust

Completed

Coronary Microcirculatory and Bioresorbable Vascular Scaffolds (EMPIRE-BVS)

Myocardial Ischemia | Angina, Stable | CHD - Coronary Heart Disease

United Kingdom
University Hospital Ulm

Recruiting

Coronary Interventions Ulm - Coronary Chronic Total Occlusions (CSI)

Chronic Total Occlusion | Chronic Total Occlusion of Coronary Artery

Germany
Abbott Medical Devices

Completed

ABSORB II Randomized Controlled Trial (ABSORB II)

Coronary Artery Disease

Belgium
Azienda Ospedaliera Bolognini di Seriate Bergamo

Unknown

Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry (STRATEGY-IT)

ST-elevation Myocardial Infarction (STEMI)

Italy
Biotronik AG
CBCC-VIBGYOR Research Pvt. Ltd.

Suspended

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold (BIOSOLVE-India)

Coronary Artery Disease

India
Institut d'Investigació Biomèdica de Bellvitge
Fundació La Marató de TV3

Completed

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year (BVS-Flow)

Stable Angina

Spain
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Registry Study

Coronary Artery Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

Coronary Artery Disease

China
IHF GmbH - Institut für Herzinfarktforschung
Abbott Medical Devices

Completed

Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold (GABI-R)

Coronary Artery Stenosis

Germany, Austria
University of Luebeck

Terminated

Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion (SCORE-CTO)

Coronary Artery Disease

Germany
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-III)

Coronary Artery Disease

China
Yonsei University

Completed

A Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffold

Coronary Artery Disease

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

Single Coronary Vessel Disease

Malaysia
University Hospital, Toulouse
Boston Scientific Corporation

Completed

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction (COVER-AMI)

Acute Coronary Syndrome

France
Universita di Verona

Completed

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy (CART)

Cardiac Allograft Vasculopathy

Italy, Netherlands
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Lifetech Scientific (Shenzhen) Co., Ltd.

Active, not recruiting

A First-in-Man Study of IBS (IBS-FIM)

Single Coronary Vessel Disease

China
University of Freiburg

Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents (EVERBIOII)

Coronary Artery Disease

Switzerland
Yonsei University

Unknown

A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions

Coronary Artery Disease

Korea, Republic of
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis (IRIS)

Pulmonary Artery Stenosis

China
Deutsches Herzzentrum Muenchen

Unknown

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction (ISAR-Absorb MI)

Myocardial Infarction | Cardiovascular Disease | Thrombus | Primary Angioplasty

Germany
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Samsung Medical Center

Withdrawn

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold (SMART-BRS-ISR)

Coronary Artery Disease | Coronary Restenosis

Korea, Republic of
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
Abbott Medical Devices

Terminated

ABSORB PHYSIOLOGY Clinical Investigation

Coronary Artery Disease

Netherlands, Australia, Singapore, China
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease (ABSORB-LONG)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Joost Daemen
Horizon 2020 - European Commission; REVA Medical, Inc.

Recruiting

FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

Percutaneous Coronary Intervention | Tomography, Optical Coherence | Myocardial Revascularization

Netherlands, Belgium
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors International

Active, not recruiting

The OCT SORT-OUT VIII Study (OCT SORT-OUT)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris

Denmark
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands

Search clinical trials for: AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations